http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100839394-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100839394-B1 |
| titleOfInvention | Pyrazolo pyrimidine |
| abstract | The novel pyrazolopyrimidines of the formula (I) are discussed. Such pyrazolopyrimidines inhibit the activity of cyclin-dependent kinases, most particularly cyclin-dependent kinase 1 (Cdk1), cyclin-dependent kinase 2 (Cdk2), and cyclin-dependent kinase 4 (Cdk4). And thus are particularly useful for the treatment or control of cancer, in particular solid tumors. The present invention also provides pharmaceutical compositions containing the compounds and methods of treating or controlling cancer, most particularly the treatment or control of breast, lung, colon and prostate tumors:n n n . |
| priorityDate | 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.